Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy
International Journal of Radiation Oncology*Biology*Physics · 2023
DOI: 10.1016/j.ijrobp.2023.02.020 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2023. Verfasst von Bradford S Hoppe und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida. Electronic address: hoppe.bradford@mayo.edu. Hauptthemen laut MEDLINE: Hodgkin Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE: We investigated the effects of central review of the interim fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scan response (iPET) assessment on treatment allocation in the risk-based, response-adapted, Children's Oncology Group study AHOD1331 (ClinicalTrials.gov identifier: NCT02166463) for pediatric patients with high-risk Hodgkin lymphoma. METHODS AND MATERIALS: Per protocol, after 2 cycles of systemic therapy, patients underwent iPET, with visual response assessment by 5-point Deauville score (DS) at their treating institution and a real-time central review, with the latter considered the reference standard. An area of disease with a DS of 1 to 3 was considered a rapid-responding lesion, whereas a DS of 4 to 5 was considered a slow-responding lesion (SRL). Patients with 1 or more SRLs were considered iPET positive, whereas patients with only rapid-responding lesions were considered iPET negative. We conducted a predefined exploratory evaluation of concordance in iPET response assessment between institutional and central reviews of 573 patients. The concordance rate was evaluated using the Cohen κ statistic (κ > 0.80 was considered very good agreement and κ > 0.60-0.80, good agreement). RESULTS: The concordance rate (514 of 573 [89.7%]) had a κ of 0.685 (95% CI, 0.610-0.759), consistent with good agreement. In terms of the direction of discordance, among the 126 patients who were considered iPET positive by institutional review, 38 (30.2%) were categorized as iPET negative by central review, preventing overtreatment with radiation therapy. Conversely, among the 447 patients who were considered iPET negative by institutional review, 21 patients (4.7%) were categorized as iPET positive by the central review and would have been undertreated without radiation therapy. CONCLUSIONS: Central review is integral to PET response-adapted clinical trials for children with Hodgkin lymphoma. Continued support of central imaging review and education about DS are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida. Electronic address: hoppe.bradford@mayo.edu.
- Pediatric Radiology, Imaging and Radiation Oncology Core Rhode Island, Lincoln, Rhode Island.
- Children's Oncology Group Statistics and Data Center, Department of Biostatistics, University of Florida, Gainesville, Florida.
- Department of Radiology and Imaging Sciences, Emory University and Children's Healthcare of Atlanta-Egleston Hospital, Decatur, Georgia.
- Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.
- Department of Radiology, Children's Health of Orange County, Orange, California.
Förderung
- NCI NIH HHS
Zitieren
APA
Hoppe, B. S., McCarten, K. M., Pei, Q., Kessel, S., Alazraki, A., Mhlanga, J. C., Lai, H. A., Eutsler, E., Hodgson, D. C., Roberts, K. B., Charpentier, A. M., Keller, F. G., Voss, S. D., Wu, Y., Cho, S. Y., Kelly, K. M., & Castellino, S. M. (2023). Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2023.02.020
Vancouver
Hoppe BS, McCarten KM, Pei Q, Kessel S, Alazraki A, Mhlanga JC, et al. Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 2023. doi:10.1016/j.ijrobp.2023.02.020
BibTeX
@article{Hoppe2023,
author = {Hoppe, Bradford S and McCarten, Kathleen M and Pei, Qinglin and Kessel, Sandy and Alazraki, Adina and Mhlanga, Joyce C and Lai, Hollie A and Eutsler, Eric and Hodgson, David C and Roberts, Kenneth B and Charpentier, Anne-Marie and Keller, Frank G and Voss, Stephan D and Wu, Yue and Cho, Steve Y and Kelly, Kara M and Castellino, Sharon M},
title = {Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2023},
doi = {10.1016/j.ijrobp.2023.02.020}
}
EUVIMED